Inivata is a Leader in Liquid Biopsy

Unlocking essential genomic information from a simple
blood draw to transform the care of cancer patients

Inivata is a Leader in Liquid Biopsy

Unlocking essential genomic information from a simple
blood draw to transform the care of cancer patients

Liquid Biopsy Unlocking essential genomic information from a simple blood draw to transform the care of cancer patients

InVision® platform

Our InVision® platform unlocks essential genomic information from a simple blood draw to transform the care of cancer patients

InVisionFirst®Lung Our US Medicare-reimbursed lead product InVisionFirst®Lung is already transforming the lives of advanced NSCLC patients

InVisionFirst®Lung

Our US Medicare-reimbursed lead product InVisionFirst®Lung is already transforming the lives of advanced NSCLC patients

Radar™  A multi-tumor assay for the detection of residual disease and recurrence based on the InVision® liquid biopsy platform

Radar

A multi-tumor assay for the detection of residual disease and recurrence based on the InVision® liquid biopsy platform

Our Mission

We are transforming the lives of cancer patients and their families through the power of liquid biopsy

InvisionFirst Lung - ctDNA Liquid Biopsy Test

Our Technology - Liquid Biopsy Testing

Our Technology

Contact Us at Inivata

Contact Us

Latest News and Events

US Commercial Launch of InVisionFirst®-Lung

Inivata’s Liquid Biopsy Test for Advanced Non-Small Cell Lung Cancer is Now Available Through NeoGenomics in the US Read More

ctDNA detection in early-stage non-small cell lung cancer

Katrin Heider, Jonathan C.M. Wan,  Davina Gale – PRESENTING AUTHOR, Andrea Ruiz-Valdepenas, Florent Mouliere, James Morris, Wendi Read More

World Conference on Lung Cancer 2020

World Conference on Lung Cancer 2020

Event expiration date display - 26 - 29 JAN 2021

Location: Singapore Read More

Changing Lives

Patients are at the heart of everything we do.

Our first product is for advanced Non-Small Cell lung Cancer and our world-leading tests are already impacting patients’ lives. 

This is the story of the first patient Inivata tested.

Transforming the lives of Cancer Patients and Their Families

As a dynamic and innovative company, we focus on the development of ground-breaking technology in a fast-paced and international setting.

Our team of talented and driven individuals work together to combine their energy and expertise in world-class research, product development and commercialization. Join us.

NeoGenomics is your single laboratory resource for comprehensive and targeted biomarker testing for tissue testing and liquid biopsy. Now offering InVisionFirst®- Lung, NeoLAB® Solid Tumor and PIK3CA Mutation CDx #LiquidBiopsy tests.
https://bit.ly/2CAAXAo
#precisionmedicine

BioBoss podcast—Inivata CEO Clive Morris; https://lnkd.in/dNAUjAb & https://lnkd.in/dP_PrXX. Hear Clive share his thoughts with BioBoss host John Simboli about leadership, Inivata advances in non-invasive liquid biopsy
@Inivata,#liquidbiopsy,#cancer,#oncology,#openscience,#ctDNA

Our CEO Clive Morris recently joined @WsgJohn on the @BioBossPodcast to talk about his career journey, and what leading Inivata is like - listen to it here: https://tinyurl.com/yd26tzcx
#LifeSciences #Podcast #Leadership